Clinical Validation of Vital-PICASO for Predicting Hypotension Within 24 Hours in General Ward Inpatients
Clinical Validity of an AI-Based Biological Signal Analysis Software Vital-PICASO for Predicting the Risk of Hypotension Within 24hrs Using Vital Sign (SBP, DBP, HR, RR, BT, SpO2) From General Ward Inpatients; A Retrospective, Single-Center, Single-Arm, Superiority-Confirmatory Clinical Trial
1 other identifier
observational
648
1 country
1
Brief Summary
This retrospective study evaluated the clinical performance of Vital-PICASO, an artificial intelligence-based biological signal analysis software designed to predict the risk of hypotension within 24 hours using vital-sign data from adult general ward inpatients. Electronic medical record data from patients aged 19 years or older who were admitted to a general ward at Seoul National University Hospital were retrospectively reviewed. Hypotension was defined as systolic blood pressure below 90 mmHg. Eligible data were classified as hypotension-positive or hypotension-negative according to predefined reference-standard criteria. Vital-PICASO was applied to the selected vital-sign datasets, and the software-generated hypotension risk scores were compared with the reference-standard classifications. Predictive performance was evaluated separately using data that included oxygen saturation and data that excluded oxygen saturation. Because the study used previously collected medical records, there was no direct participant contact and the software results were not used to guide patient care.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jul 2025
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 21, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
May 13, 2026
CompletedFirst Submitted
Initial submission to the registry
July 29, 2026
CompletedFirst Posted
Study publicly available on registry
August 3, 2026
CompletedAugust 3, 2026
July 1, 2026
8 months
July 29, 2026
July 29, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Area Under the Receiver Operating Characteristic Curve for Hypotension Prediction With SpO2
The area under the receiver operating characteristic curve (AUROC) was calculated by comparing the hypotension risk scores generated by Vital-PICASO with the reference-standard classification of hypotension-positive or hypotension-negative. The analysis included systolic blood pressure, diastolic blood pressure, heart rate, respiratory rate, body temperature, and oxygen saturation as input variables. Hypotension was defined as systolic blood pressure below 90 mmHg. AUROC ranges from 0 to 1, with a higher value indicating better discrimination. The prespecified success criterion was met if the lower bound of the 95% confidence interval for the difference between the Vital-PICASO AUROC and the comparator AUROC of 0.7847 was greater than 0.
During the 24-hour period before the hypotension event or corresponding reference time point
Area Under the Receiver Operating Characteristic Curve for Hypotension Prediction Without SpO2
The area under the receiver operating characteristic curve (AUROC) was calculated by comparing the hypotension risk scores generated by Vital-PICASO with the reference-standard classification of hypotension-positive or hypotension-negative. The analysis included systolic blood pressure, diastolic blood pressure, heart rate, respiratory rate, and body temperature as input variables, without oxygen saturation. Hypotension was defined as systolic blood pressure below 90 mmHg. AUROC ranges from 0 to 1, with a higher value indicating better discrimination. The prespecified success criterion was met if the lower bound of the 95% confidence interval for the difference between the Vital-PICASO AUROC and the comparator AUROC of 0.7847 was greater than 0.
During the 24-hour period before the hypotension event or corresponding reference time point
Secondary Outcomes (7)
Area Under the Precision-Recall Curve for Hypotension Prediction With SpO2
During the 24-hour period before the hypotension event or corresponding reference time point
Area Under the Precision-Recall Curve for Hypotension Prediction Without SpO2
During the 24-hour period before the hypotension event or corresponding reference time point
Precision, Recall, and F1 Score Across Prespecified Risk-Score Thresholds
During the 24-hour period before the hypotension event or corresponding reference time point
Predictive Performance by Prediction-Time Interval
At 0 to 1, 1 to 6, 6 to 12, and 12 to 24 hours before the hypotension event or corresponding reference time point
Predictive Performance by Cumulative Prediction Window
Up to 24 hours before the hypotension event or corresponding reference time point
- +2 more secondary outcomes
Study Arms (2)
Hypotension-Positive Group
Adult general ward inpatient data with an eligible hypotension event, defined as systolic blood pressure below 90 mmHg, occurring in the general ward. Vital-sign data collected for up to 72 hours before the first eligible hypotension event were included. If hypotension occurred within 24 hours after admission or transfer to the general ward, all available vital-sign data recorded before the event were included, provided that at least 12 hours of data were available.
Hypotension-Negative Group
Adult general ward inpatient data from patients who did not experience hypotension during the selected general ward admission. Data were randomly selected from the same general wards as the hypotension-positive group and from a time interval comparable with the hypotension event reference time or from up to 72 hours after admission to the general ward. Only one eligible data interval was selected per patient.
Eligibility Criteria
The study population consisted of adult patients aged 19 years or older who were admitted to a general ward at Seoul National University Hospital and had at least 12 hours of electronic medical record data available between January 1, 2023, and May 31, 2025. The retrospective study dataset included patients with an eligible hypotension event occurring in a general ward and patients without hypotension during the selected general ward admission period. Hypotension was defined as systolic blood pressure below 90 mmHg.
You may qualify if:
- General Criteria
- Male or female patient aged 19 years or older at the time the clinical data were recorded
- Electronic medical record data available between January 1, 2023, and May 31, 2025
- Admission to a general ward for at least 12 hours
- Clinical data not previously used in the development of Vital-PICASO
- Hypotension-Positive Group
- Hypotension occurred in a general ward
- Hypotension was defined as systolic blood pressure below 90 mmHg
- Vital-sign data were available for up to 72 hours before the hypotension event
- If hypotension occurred within 24 hours after admission or transfer to the general ward, all available vital-sign data recorded before the event were included
- If a patient experienced multiple hypotension events during the data collection period, only the first eligible event was included
- Hypotension-Negative Group
- No hypotension occurred during the selected general ward admission period
- Data were randomly selected from the same general wards as the hypotension-positive group
- Vital-sign data were available from a time interval comparable with the hypotension event reference time or for up to 72 hours after admission to the general ward
- +1 more criteria
You may not qualify if:
- Hypotension occurred outside a general ward
- A do-not-resuscitate order was in effect at the time of data collection
- Pregnancy at the time of data collection or within 3 months after delivery
- The data were considered inappropriate for the study by the principal investigator
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Huinno AIMlead
Study Sites (1)
Seoul National University Hospital
Seoul, South Korea
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 29, 2026
First Posted
August 3, 2026
Study Start
July 21, 2025
Primary Completion
April 1, 2026
Study Completion
May 13, 2026
Last Updated
August 3, 2026
Record last verified: 2026-07
Data Sharing
- IPD Sharing
- Will not share